Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern A Matas-García, JC Milisenda, A Selva-O'Callaghan, S Prieto-González, ... Autoimmunity Reviews 19 (2), 102455, 2020 | 54 | 2020 |
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19 C Garcia-Vidal, R Alonso, AM Camon, C Cardozo, L Albiach, D Agüero, ... Journal of Antimicrobial Chemotherapy 76 (12), 3296-3302, 2021 | 37 | 2021 |
Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019 M Serrano, G Espinosa, A Lalueza, LY Bravo‐Gallego, R Diaz‐Simón, ... ACR Open Rheumatology 3 (4), 267-276, 2021 | 23 | 2021 |
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19 AM Camon, R Alonso, FJ Muñoz, C Cardozo, J Bernal-Maurandi, ... Scientific reports 12 (1), 5250, 2022 | 16 | 2022 |
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis I Pinal-Fernandez, A Quintana, JC Milisenda, M Casal-Dominguez, ... Annals of the rheumatic diseases 82 (6), 829-836, 2023 | 14 | 2023 |
Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation … Ò Miró, K Takagi, É Gayat, V Gil, P Llorens, FJ Martín-Sánchez, J Jacob, ... Clinical Research in Cardiology 109, 34-45, 2020 | 11 | 2020 |
Persistent antiphospholipid antibodies are not associated with worse clinical outcomes in a prospective cohort of hospitalised patients with SARS-CoV-2 infection G Espinosa, C Zamora-Martínez, A Pérez-Isidro, D Neto, O Viñas, ... Frontiers in Immunology 13, 911979, 2022 | 8 | 2022 |
Prevalence of ethical dilemmas in advanced cancer patients (secondary analysis of the PALCOM study) A Tuca, M Viladot, C Barrera, M Chicote, I Casablancas, C Cruz, E Font, ... Supportive Care in Cancer 29, 3667-3675, 2021 | 8 | 2021 |
Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study Ò Miró, J Padrosa, K Takagi, É Gayat, V Gil, P Llorens, FJ Martín-Sánchez, ... European Journal of Internal Medicine 70, 24-32, 2019 | 7 | 2019 |
Comparison of the quick sepsis-related organ dysfunction score and severity levels assigned with the Andorran triage model in an urban tertiary care hospital emergency department EM Cols, AU Ramos, CG Xanco, AL Vasquez, JP Pulido, MO Romero Emergencias: revista de la Sociedad Espanola de Medicina de Emergencias 30 …, 2018 | 7 | 2018 |
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature NL Guerra, A Matas-García, L Serra-García, D Morgado-Carrasco, ... Autoimmunity Reviews, 103375, 2023 | 3 | 2023 |
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies I Pinal-Fernandez, JC Milisenda, K Pak, S Muñoz-Braceras, ... Annals of the rheumatic diseases 82 (8), 1091-1097, 2023 | 2 | 2023 |
Encephalitis associated with immune checkpoint inhibitor treatment in patients with melanoma C Martínez-Vila, JC Laguna, E Segui, G Ruiz, FA Moreno, ... Journal of Immunotherapy 44 (5), 204-207, 2021 | 2 | 2021 |
Validation Study of the PALCOM Scale of Complexity of Palliative Care Needs: A Cohort Study in Advanced Cancer Patients M Viladot, JL Gallardo-Martínez, F Hernandez-Rodríguez, J Izcara-Cobo, ... Cancers 15 (16), 4182, 2023 | 1 | 2023 |
Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis J Cantó-Santos, L Valls-Roca, E Tobías, C Oliva, FJ García-García, ... Antioxidants 12 (8), 1639, 2023 | 1 | 2023 |
Differentiating acute interstitial nephritis from immune checkpoint inhibitors from other causes J Casals, Y Acosta, G Caballero, L Morantes, C Zamora, M Xipell, ... Kidney International Reports 8 (3), 672-675, 2023 | 1 | 2023 |
Severe Immune-Related Adverse Events: A Case Series of Patients Needing Hospital Admission in a Spanish Oncology Referral Center and Review of the Literature E Seguí, C Zamora-Martínez, TD Barreto, J Padrosa, M Viladot, ... Diagnostics 12 (9), 2116, 2022 | 1 | 2022 |
P09. 15 Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19 L Fernández-Mañas, T Gorría, E Auclin, R Reyes, C Teixidó, ... Journal of Thoracic Oncology 16 (3), S294-S295, 2021 | 1 | 2021 |
Statin use and myopathy. Not always guilty MN Antoniol, PJ Moreno, JC Milisenda, A Selva O’Callaghan, JM Grau, ... Rheumatology 59 (12), 3853-3857, 2020 | 1 | 2020 |
Maneig de la sèpsia en un servei d'Urgències hospitalàries d'un centre de tercer nivell. Oportunitats de millora E Monclús Cols Universitat de Barcelona, 2019 | 1 | 2019 |